Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
3,650
datasets available to search
ShareScore release 0.9.0
Dataset results
3,650 results for “antibody”
Tyrosine Kinase Inhibitor (TKI) + Anti-PD-1 Antibody in TKI-responded Microsatellite Stability/Proficient Mismatch Repair (MSS/pMMR) Metastatic Colorectal Adenocarcinoma.
ClinicalTrials.gov study NCT04483219. IPD Sharing: YES. Countries: 1. Publications: 1.
Study of Antibody Responses After a Dose of Tetravalent Meningococcal Diphtheria Conjugate Vaccine in Children
ClinicalTrials.gov study NCT00771849. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Anti-neutrophil Cytoplasmic Antibody in Interstitial Lung Disease.
ClinicalTrials.gov study NCT04413149. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Persistence of Antibodies at 3, 4 and 6 Years of Age After Vaccination With Meningococcal, Pneumococcal and Hib Vaccines
ClinicalTrials.gov study NCT00891176. IPD Sharing: YES. Countries: 3. Publications: 1.
Use of Behavioral Economics in Repeat SARS-CoV-2 (COVID-19) Antibody Testing in Disadvantaged Communities
ClinicalTrials.gov study NCT04901624. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Perioperative MVT-5873, a Fully Human Monoclonal Antibody Against a CA 19-9 Epitope, for Operable CA 19-9 Producing Pancreatic Cancers, Cholangiocarcinomas, and Metastatic Colorectal Cancers
ClinicalTrials.gov study NCT03801915. IPD Sharing: YES. Countries: 1. Publications: 1.
Phase II Study With the Trifunctional Antibody Ertumaxomab to Treat Metastatic Breast Cancer After Progression on Trastuzumab Therapy
ClinicalTrials.gov study NCT00522457. IPD Sharing: Not stated. Countries: 2. Publications: 5.
SARS-CoV-2-Neutralizing Monoclonal COVID-19 Antibody DZIF-10c by Infusion
ClinicalTrials.gov study NCT04631666. IPD Sharing: NO. Countries: 1. Publications: 2.
Phase 2 Study of the Monoclonal Antibody MGAH22 (Margetuximab) in Patients With Relapsed or Refractory Advanced Breast Cancer
ClinicalTrials.gov study NCT01828021. IPD Sharing: NO. Countries: 1. Publications: 1.
Monoclonal Antibody 3F8 and Sargramostim in Treating Patients With Neuroblastoma
ClinicalTrials.gov study NCT00072358. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects -2
ClinicalTrials.gov study NCT01763905. IPD Sharing: Not stated. Countries: 14. Publications: 11.
A First Human Study of a Ferroportin Antibody
ClinicalTrials.gov study NCT01330953. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Monoclonal Antibody Therapy and Vaccine Therapy in Treating Patients With Resected Stage III or Stage IV Melanoma
ClinicalTrials.gov study NCT00084656. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Randomized Controlled Trial of Eculizumab in AQP4 Antibody-positive Participants With NMO (PREVENT Study)
ClinicalTrials.gov study NCT01892345. IPD Sharing: Not stated. Countries: 18. Publications: 6.
Evaluating the Safety and Efficacy of the VRC01 Antibody in Reducing Acquisition of HIV-1 Infection in Women
ClinicalTrials.gov study NCT02568215. IPD Sharing: Not stated. Countries: 7. Publications: 7.
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Neutralizing Antibody BGB-DXP593 in Participants With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19)
ClinicalTrials.gov study NCT04551898. IPD Sharing: YES. Countries: 4. Publications: 2.
Efficacy and Safety of Human Plasma-derived C1-esterase Inhibitor as add-on to Standard of Care for the Treatment of Refractory Antibody Mediated Rejection (AMR) in Adult Renal Transplant Recipients
ClinicalTrials.gov study NCT03221842. IPD Sharing: NO. Countries: 7. Publications: 1.
Evaluation of Anti-Hemagglutinin (Anti-HA) Antibodies as Protection From the Flu in Healthy People
ClinicalTrials.gov study NCT01971255. IPD Sharing: YES. Countries: 1. Publications: 5.
Safety, Pharmacokinetic and Pharmacodynamic Study of COR-1, an Anti-ß1 Receptor Antibody Cyclopeptide
ClinicalTrials.gov study NCT01043146. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of Atezolizumab (Anti-PD-L1 Antibody) as Adjuvant Therapy After Definitive Local Therapy in Patients With High-Risk Locally Advanced Squamous Cell Carcinoma of the Head and Neck
ClinicalTrials.gov study NCT03452137. IPD Sharing: Not stated. Countries: 23. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.